BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2894774)

  • 1. Sites of action of mu-, kappa- and sigma-opiate receptor agonists at the feline ileocecal sphincter.
    Ouyang A; Vos P; Cohen S
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G224-31. PubMed ID: 2894774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of opiate-mediated responses of the feline ileum and ileocecal sphincter.
    Ouyang A; Clain CJ; Snape WJ; Cohen S
    J Clin Invest; 1982 Mar; 69(3):507-15. PubMed ID: 6277992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The partial opiate receptor agonists, dezocine and ciramadol act as mu receptor antagonists at the feline ileocecal sphincter.
    Ouyang A
    Life Sci; 1989; 45(16):1491-7. PubMed ID: 2572952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple 5-hydroxytryptamine receptors on feline ileum and ileocecal sphincter.
    Ouyang A; Cohen S
    Am J Physiol; 1983 Apr; 244(4):G426-34. PubMed ID: 6837748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of neurotensin at the ileocecal sphincter region.
    Rothstein RD; Ouyang A
    Life Sci; 1989; 45(16):1475-82. PubMed ID: 2811604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P: mechanism of action and receptor distribution at the feline ileocecal sphincter region.
    Rothstein RD; Johnson E; Ouyang A
    Am J Physiol; 1989 Sep; 257(3 Pt 1):G447-53. PubMed ID: 2476938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ileocecal sphincter contraction to colonic distension: a tachykinin-mediated spinal reflex.
    Rothstein RD; DeRiso J; Ouyang A
    Am J Physiol; 1990 Apr; 258(4 Pt 1):G585-90. PubMed ID: 1692186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of opioids on primate spinothalamic tract neurons.
    Willcockson WS; Kim J; Shin HK; Chung JM; Willis WD
    J Neurosci; 1986 Sep; 6(9):2509-20. PubMed ID: 2875139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of N-allylnormetazocine on electric shock titration in squirrel monkeys.
    Slifer BL; Dykstra LA
    Alcohol Drug Res; 1987; 7(4):217-24. PubMed ID: 3030339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a direct and indirect action of leucine enkephalin at the feline ileocecal sphincter.
    Bertiger G; Ouyang A; Reynolds JC; Cohen S
    Life Sci; 1988; 42(18):1697-703. PubMed ID: 2896285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties.
    Khazan N; Young GA; El-Fakany EE; Hong O; Calligaro D
    Neuropharmacology; 1984 Aug; 23(8):983-7. PubMed ID: 6090969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.